Cash Flow Statement

Daily Values

Growth Metrics

Others

Ratios

Asset Utilization Ratio Assets Average EBIT Margin EBITDA Margin EBT Margin Enterprise Value Equity Average Equity Ratio FCF Margin Interest Coverage Ratio Invested Capital Net Margin Operating Margin Return on Assets Return on Capital Employed Return on Equity Return on Sales Times Interest Earned

Contineum Therapeutics (CTNM) Return on Invested Capital (2023 - 2024)

Contineum Therapeutics has reported Return on Invested Capital over the past 2 years, most recently at 0.2% for Q3 2024.